FDA Approves Use of Prescription Fish Oil To Reduce Risk of Cardiovascular Events
December 22, 2019
*FDA Newsroom/Press Announcement/Dec 13th, 2019* The U.S. Food and Drug Administration today approved the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat
Interested in a specific topic? Immune Support Eyes Lose Weight Allergy Sports COVID-19
Byclue Nutrition ™
Supplementation with Knowledge
30 top U.S. brands
200 types of nutritional supplements
5,000+ popular products
One platform: byclue.com
Knowledge
Research-based, authoritative, unbiased nutritional science knowledge base. We update blog weekly
Brands
How to find popular and premium brands among consumers and healthcare practitioners
Products
We help you choose best supplements based on your health needs
Platform
Buy directly and ship gloablly from iHerb . Enjoy the best prices and shipping service
Free Subscription，for now!
Access to website articles, blogs, webinars and features; Priority inquiry and commenting; 10% reward code… The $199/year subscription fee waived!Tips:
- Think you know everything about fish oil? Wait until you read our Fish Oil Omega-3s page.
- Want to know what supplements you may need? Why not take one or all of the Top 12 Blood Tests?
Share the love: